BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 26897855)

  • 21. Personalised cancer medicine.
    Jackson SE; Chester JD
    Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized cancer medicine and the future of pathology.
    Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD
    Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic Medicine Takes the Stage, Again!
    Tempero M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
    [No Abstract]   [Full Text] [Related]  

  • 24. Precision medicine strategies in oncology: mixed approaches to matched therapies.
    Borcoman E; Le Tourneau C
    Future Oncol; 2018 Jan; 14(2):105-109. PubMed ID: 29224361
    [No Abstract]   [Full Text] [Related]  

  • 25. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer diagnostics: The journey from histomorphology to molecular profiling.
    Ahmed AA; Abedalthagafi M
    Oncotarget; 2016 Sep; 7(36):58696-58708. PubMed ID: 27509178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An integrated framework for reporting clinically relevant biomarkers from paired tumor/normal genomic and transcriptomic sequencing data in support of clinical trials in personalized medicine.
    Nasser S; Kurdolgu AA; Izatt T; Aldrich J; Russell ML; Christoforides A; Tembe W; Keifer JA; Corneveaux JJ; Byron SA; Forman KM; Zuccaro C; Keats JJ; Lorusso PM; Carpten JD; Trent JM; Craig DW
    Pac Symp Biocomput; 2015; ():56-67. PubMed ID: 25592568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Future of Precision Medicine in Oncology.
    Millner LM; Strotman LN
    Clin Lab Med; 2016 Sep; 36(3):557-73. PubMed ID: 27514468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of cancer next-generation sequencing testing in a community hospital.
    Akkari Y; Smith T; Westfall J; Lupo S
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budget impact and cost-effectiveness: can we afford precision medicine in oncology?
    Doble B
    Scand J Clin Lab Invest Suppl; 2016; 245():S6-S11. PubMed ID: 27426412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Personalized medicine in oncology].
    Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
    Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput sequencing in clinical oncology: from past to present.
    Mery B; Vallard A; Rowinski E; Magne N
    Swiss Med Wkly; 2019 Mar; 149():w20057. PubMed ID: 30946479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Precision Oncology: Approaching the Target].
    Hiddemann W
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
    [No Abstract]   [Full Text] [Related]  

  • 37. The importance of precision medicine in modern molecular oncology.
    Wang Y; Zheng D
    Clin Genet; 2021 Sep; 100(3):248-257. PubMed ID: 33997970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
    Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
    Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic therapy in cancer: perspective and paradoxes.
    Filosa A; Fabiani A
    Anal Quant Cytol Histol; 2011 Oct; 33(5):303-4. PubMed ID: 22611759
    [No Abstract]   [Full Text] [Related]  

  • 40. Precision cancer medicine: the future is now, only better.
    Tsimberidou AM; Eggermont AM; Schilsky RL
    Am Soc Clin Oncol Educ Book; 2014; ():61-9. PubMed ID: 24857061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.